Hristov et al., 2019 - Google Patents
Designing paper-based immunoassays for biomedical applicationsHristov et al., 2019
View HTML- Document ID
- 14095764081602399090
- Author
- Hristov D
- Rodriguez-Quijada C
- Gomez-Marquez J
- Hamad-Schifferli K
- Publication year
- Publication venue
- Sensors
External Links
Snippet
Paper-based sensors and assays have been highly attractive for numerous biological applications, including rapid diagnostics and assays for disease detection, food safety, and clinical care. In particular, the paper immunoassay has helped drive many applications in …
- 238000004166 bioassay 0 abstract description 121
Classifications
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by the preceding groups
- G01N33/48—Investigating or analysing materials by specific methods not covered by the preceding groups biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/53—Immunoassay; Biospecific binding assay
- G01N33/543—Immunoassay; Biospecific binding assay with an insoluble carrier for immobilising immunochemicals
- G01N33/54366—Apparatus specially adapted for solid-phase testing
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by the preceding groups
- G01N33/48—Investigating or analysing materials by specific methods not covered by the preceding groups biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/53—Immunoassay; Biospecific binding assay
- G01N33/569—Immunoassay; Biospecific binding assay for micro-organisms, e.g. protozoa, bacteria, viruses
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by the preceding groups
- G01N33/48—Investigating or analysing materials by specific methods not covered by the preceding groups biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/5005—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N21/00—Investigating or analysing materials by the use of optical means, i.e. using infra-red, visible or ultra-violet light
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| Hristov et al. | Designing paper-based immunoassays for biomedical applications | |
| Omidfar et al. | Lateral flow assay: a summary of recent progress for improving assay performance | |
| Hsiao et al. | Recent advances in novel lateral flow technologies for detection of COVID-19 | |
| Majdinasab et al. | Aptamer-based lateral flow assays: current trends in clinical diagnostic rapid tests | |
| Anfossi et al. | Multiplex lateral flow immunoassay: an overview of strategies towards high-throughput point-of-need testing | |
| Saylan et al. | An alternative medical diagnosis method: biosensors for virus detection | |
| Serebrennikova et al. | Lateral flow immunoassay of SARS-CoV-2 antigen with SERS-based registration: development and comparison with traditional immunoassays | |
| Ardekani et al. | Gold nanoparticle-mediated lateral flow assays for detection of host antibodies and COVID-19 proteins | |
| Parkash et al. | Diagnosis of dengue infection using conventional and biosensor based techniques | |
| Manessis et al. | Point-of-care diagnostics for farm animal diseases: from biosensors to integrated lab-on-chip devices | |
| Pomili et al. | Based multiplexed colorimetric device for the simultaneous detection of salivary biomarkers | |
| Chen et al. | Multiplex detection of infectious diseases on microfluidic platforms | |
| Lei et al. | Design of gold nanoparticle vertical flow assays for point-of-care testing | |
| Ahmad Najib et al. | Quantum dot-based lateral flow immunoassay as point-of-care testing for infectious diseases: A narrative review of its principle and performance | |
| Kim et al. | SERS-based immunoassays for the detection of botulinum toxins A and B using magnetic beads | |
| Rahman | Progress in electrochemical biosensing of SARS-CoV-2 virus for COVID-19 management | |
| Xu et al. | Recent advances of representative optical biosensors for rapid and sensitive diagnostics of SARS-CoV-2 | |
| Mousavi et al. | Recent advances in quantum dot-based lateral flow immunoassays for the rapid, point-of-care diagnosis of COVID-19 | |
| Panferov et al. | Comparative study of in situ techniques to enlarge gold nanoparticles for highly sensitive lateral flow immunoassay of SARS-CoV-2 | |
| Kim et al. | Silver-assembled silica nanoparticles in lateral flow immunoassay for visual inspection of prostate-specific antigen | |
| Trinh et al. | Recent advances in molecular and immunological diagnostic platform for virus detection: A review | |
| Bikkarolla et al. | High-sensitive detection and quantitative analysis of thyroid-stimulating hormone using gold-nanoshell-based lateral flow immunoassay device | |
| Cavalera et al. | Switching from multiplex to multimodal colorimetric lateral flow immunosensor | |
| Bacon et al. | Review of HIV self testing technologies and promising approaches for the next generation | |
| Seele et al. | Development of gold-nanoparticle-based lateral flow immunoassays for rapid detection of TB ESAT-6 and CFP-10 |